Table 3.
Response per patient, organized by diagnosis
| Diagnosis | Patient sex or diagnosis group | Age, years | Number of prior therapies** | Best response / ORR (CR+PR) per diagnosis, % | Prior stem cell transplantation |
|---|---|---|---|---|---|
| HL | M | 22 | 3 | PD | - |
| F | 27 | 11 | PR | Allogeneic | |
| M | 49 | 4 | CR | Autologous | |
| M | 36 | 5 | PD | - | |
| All patients | 50% | ||||
| MM | M | 74 | 4 | NA* | Autologous |
| M | 66 | 9 | PR | Autologous | |
| M | 67 | 6 | VGPR | Autologous | |
| M | 60 | 10 | PD | Autologous | |
| M | 73 | 5 | PR | Autologous | |
| F | 62 | 5 | PR | Autologous | |
| All patients | 80% | ||||
| MCL | M | 67 | 2 | CR | Autologous |
| All patients | 100% | ||||
| FL | M | 51 | 1 | CR | - |
| M | 73 | 3 | CR | - | |
| All patients | 100% | ||||
| DLBCL | M | 61 | 4 | PD | - |
| F | 59 | 3 | DLT | - | |
| M | 70 | 3 | PD | - | |
| M | 66 | 3 | PD | Autologous | |
| M | 61 | 4 | PR | Autologous | |
| All patients | 20% |
*
The patient withdrew from the study after cycle 1 and refused follow-up.
**
Including autologous or allogeneic stem cell transplantation.
Abbreviations: M = Male; F = Female; ORR = overall response rate; CR = complete response; PR = partial response; PD = progressive disease; NA = non-applicable; VGPR= very good partial response; DLT = dose-limiting toxicity